Measurement of total and trlmethyl lead in mammalian tissue is described, using ion exchange/high performance liquid chromatography in tandem with flameless atomic absorption spectrometry for lead-specific detection. All lead forms in whole blood and homogenates of soft tissue--brain, kidney, and liver--were liberated from tissue binding by treatment with dilute (3N) HCl for a period of 18 hr. Trimethyl lead was partitioned Into chloroform/ethyl acetate after media neutralization to pH of approximately 4 and saturation with sodium chloride. The extract was chromatographically analyzed on a Partisil SCX-10 cation exchange column, using 0.167M ammonium citrate In methanol:water (70:30) as mobile phase. Fractions of eluate were collected using a programmable fraction collector, and the fractions collected from 3.5 to 5.0 min were analyzed by atomic absorption spectrometry. Total lead In tissue was measured by acid wet digestion and flameless atomic absorption spectrometry. The difference in the values from both analyses provided a measure of any trlmethyl lead metabolltes.
Introduction
It is now generally accepted that analytical methods which permit chemical speciation among biologically active organometallic toxicants and pollutants are more useful in assessing the nature and mechanisms of toxic action than are those which yield only total level of the core element. In the particular case of the neurotoxic alkyl lead compounds, such recognition has been reflected in the growing number of reports describing formspecific organolead analysis in various types of media. These reports describe approaches which vary in how discrete forms are quantitated. In a number of cases, isolation of alkyl lead as the halide, dithizonate, or diethyldithiocarbamate (1-3) into an organic phase is followed by phenylation (l) or butylation (2,3) using Grignard reagents and quantitation by various detection means. Other speciation approaches are more limited, e.g., triethyl lead measurement as described by Bolanowska et al. (4) and the triethyl/trimethyl lead methodology of De Jonghe and coworkers (5) .
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In connection with studies of the toxicokinetic behavior of various alkyl lead (IV) compounds in the present animal models of alkyl lead neuropathology, the authors have pursued development of methodology for specific analysis of trimethyl lead in various experimental tissues from tfirnethyl lead-dosed animals using high performance liquid chromatography (HPLC) and atomic absorption spectrometry (AAS) as lead-specific detector. Simultaneous measurement of total lead permits the estimation, by difference, of any organolead metabolites. In the course of these studies, the key problem of reliable means of liberating trimethyl lead and its metabolites from tissue binding in samples from methyl lead-treated animals has been systematically examined. The latter steps are of particular value in devising chemical treatments which simultaneously leave the alkyl lead structure intact while promoting full release of various forms from tissue. Such an approach is preferable to in vitro spiking methods in the development of methodology.
Material and Methods

Reagents
Inorganic lead primary standard solution was obtained as a 1000-ppm certified stock solution of lead nitrate (Fisher Scientific Co.).
Trimethyl lead acetate and trimethyl lead chloride were obtained commercially (Alfa-Ventron) and periodically repurified by recrystallization prior to use. Ultrapure nitric and hydrochloric acids were also obtained commercially (Ultrex | J.T. Baker/American Scientific Products). Solvents (HPLC grade) were obtained from Fisher Scientific, and were both filtered and degassed prior to use.
Equipment
The HPLC system consisted of a Constametric model IIIG dual-pump apparatus (LDC) interfaced with a model 7125 syringe-loading injector (Rheodyne) and a Partisil-SCX cation exchange 10-~ column (0.46 • 25 cm) (Whatman). The eluent (isocratic mode) was 0.167M ammonium citrate in methanol: water (70:30, v/v) operated at a flow rate of 1.0 mL/min, with an injection volume of 0.2 mL. Eluate volumes were collected in acidwashed polyethylene vials, 0.5 mL per vial, using a programmable Foxy ~ fraction collector (ISCO) in order to determine the entire elution time interval. Once the elution interval is established, the entire fraction can be collected in one vessel.
Flameless AAS for both total lead and trimethyl lead analysis in HPLC fractions was carried out using a model 306 doublebeam spectrometer with a model 2100 graphite furnace atomization accessory (Perkin-Elmer). Excitation was by hollow cathode lamp using the 283.3-nm absorption line.
Gas chromatographic testing of HPLC eluate fractions for trimethyl lead employed a model 320 unit (Glowall) equipped with a silanized 18-in. glass column packed with a 4~ SE-30 on GasChrom Q (60/80 mesh), with detection of trimethyl lead as the chloride using an electrochemical (EC) (3H) detector.
Tandem gas chromatography/mass spectrometry (GC/MS) analyses of the HPLC eluates for trimethyl lead content were carried out by the Mass Spectrometry Center, Department of Environmental Sciences and Engineering, University of North Carolina at Chapel Hill.
Aqueous and Matrix-Matched Standards
Aqueous working inorganic lead solutions were prepared by appropriate dilution of certified stock solution with deionized water. Matrix-matched standards were prepared by incubation of added known amounts of either trimethyl or inorganic lead with whole blood or tissues--brain, kidney, or liver--from unexposed adult Long-Evans rats (after determination of background lead content).
In Vivo Exposure Testing
Adult Long-Evans rats were administered trimethyl lead orally at several dosing levels, (5 to 40 mg TML-OAc/kg body weight) as a means of providing lead-containing tissue for assessment of in vitro vs. in vivo recovery of lead forms.
Analytical Procedure
Control and trimethyl lead-exposed animals were anesthetized and sacrificed by cardiac puncture through the inferior vena cava. Blood was collected in a heparinized syringe and transferred to acid-washed polyethylene vials. Following this, the animals were perfused sequentially with saline solution, then formalin, to remove occluded blood from organs. Dissected organs were cut in pieces using acid-washed metal blades, weighed, and briefly rinsed with 207o EDTA solution and deionized water to strip any surface-contaminating lead.
Soft Tissue Analysis For Total and Trlmethyl Lead
Brain, liver, and kidney were homogenized in deionized water to furnish 10~ (w/v) homogenates. Vortexed homogenates were then split into 0.5-mL volumes for either total or trimethyl lead analysis, using 2-dram low-lead borosilicate, acid-washed vials.
For total lead assay, 0.5 mL of ultrapure concentrated HNO, was added to the vials and the tissue material allowed to solubilize at room temperature. Samples were then gradually heated to dryness. Residues were then brought into the solution using 1.0 mL of 3N ultrapure HCI. Micro-volumes (10 #L) of the HCI analyte solution were delivered to the graphite tube of the atomic absorption spectrometer furnace accessory, using disposable polyethylene pipette tips and an Eppendorf pipettor. Quantitation was by the method of additions using tissue matrix-matched standards prepared by the addition of known spiking amounts of either inorganic or trimethyl lead standard to control tissue homogenate. Working curves were prepared for lead levels up to 0.1 #g/mL analyte. Samples having lead content > 0.1 ttg/mL were diluted with 3N ultrapure HC1.
For measurement of trimethyl lead, 0.5 mL of tissue homogenate was treated with 6N ultrapure HCI (0.5 mL) with moderate mixing. The acid-treated samples were set aside for 18 hr. Then several drops of pyridine-2-azodimethylaniline indicator solution (0.1 ~ in absolute ethanol) were added to each vial and low-lead NaOH (3N) solution was added dropwise until the samples were a purple-red color at approximately pH 4. Solid NaCI was added to saturation and trimethyl lead chloride was partitioned into 2.0 mL of chloroform:ethyl acetate (1 : 1). The organic extracts were transferred to acid-washed polyethylene vials, and 0.2-mL aliquots were injected into the HPLC system using a programmable fraction collector set to collect 0.5-mL volumes at a rate of 1.0 mL/min in polyethylene vials. With 0.167M ammonium citrate in methanol: water (70:30, v/v) as eluent and a flow rate of 1.0 mL/min, trimethyl lead eluted over a time interval of 3.5 to 5.0 min. In routine use and with little drift in elution time, an entire sample could be collected in one vessel. Absorption signal as optical density (OD) or concentration 0zg Pb/mL) was plotted against time and the area under the peak was measured. If single-vessel collection is used, OD is used directly for standard curves. Quantitation was achieved by peak area working curves from matrix-matched standards ranging up to 0.1 p.g Pb/mL in final analyte solution.
Whole Blood Analysis for Total and Trlmethyl Lead
Small volumes of whole blood (10 to 50/zL) were added to 0.5 mL deionized water and the hemolysates were treated with 0.5 mL of ultrapure concentrated HNO~ for total lead analysis. When the solubilization was complete at room temperature, the glass vials were heated to dryness at approximately 800(]. The residue was dissolved in 3N ultrapure HCL and analyzed for total lead as described in the above-mentioned tissue analysis. For trimethyl lead analysis, similar small volumes of blood were added to deionized water, followed by treatment with 6N ultrapure hydrochloric acid. As with tissue homogenates, samples were set aside for 18 hr, NaCi added, the media neutralized, and extraction carfled out in identical fashion. High performance liquid chromatography was carried out in the same manner as was used for tissue samples, with quantitation by addition of known amounts of trimethyl lead to whole blood of control animals.
Determination of any trimethyl lead metabolites present was via subtraction of the trimethyl lead level from that of total lead.
Results
Optimization of HPLC Analysis of Trlmethyl Lead
Various HPLC column materials were evaluated for chromatographic analysis of trimethyl lead. The use of reversed-phase HPLC materials was first studied, using either acetone/pentane or acetone/hexane mixtures in an adaptation of the reported approach of Burns et al. (6) for the analysis of alkyl tin compounds. While initial results in terms of elution behavior appeared promising, a rather rapid deterioration of efficiency was noted with increasing column hold-up of the alkyl lead at the sub-ppm levels required for the authors' analytical applications. Satisfactory consistency in chromatographic behavior was obtained with a cation-exchange (10-t0 packing over extended periods of time with multiple sample analyses, using ammonium citrate (0.167M) in a methanol:water solution (70:30, v/v) as eluent. Such a system has been applied to organotin analyses (7, 8) . Use of this eluent in the isocratic mode resulted in trimethyl lead elution in a rather tight band of about 1.5 min over a 3.5-to 5.0-min time interval.
Determination of the form of extracted/chromatographed lead as solely the trimethyl species was done using GC analysis of the eluates and extracts applied to the HPLC column. Ethyl acetate was employed as extractant for this purpose. While extraction yield was lower than that of this solvent's mixture with chloro-
of trimethyl lead chloride in ethyl acetate showed that this form was extracted and subsequently chromatographed as such. That the EC detector, in turn, responded to trimethyl lead was determined by passage of the GC effluent into ultrapure nitric acid solution over the retention time observed for putative trimethyl lead chloride. Graphite furnace atomic absorption spectral analysis of this solution gave a level of lead corresponding to 100o70 recovery of the element injected into the GC system as trimethyl species. Finally, the organolead species in the HPLC eluate was characterized by tandem GC/MS, via isolation of the organolead as the chloride. The fragmentation pattern of the HPLC eluate was consistent with trimethyl lead chloride.
Extraction of Trlmethyl Lead from Acidic Aqueous Media
Unlike the case with triethyl and higher alkyl homologues of lead, it was observed that trimethyl lead was relatively more difficult to partition into organic layers from aqueous media, paralleling the experience of De Jonghe et al. (5) . These workers noted that maximum extraction of trimethyl lead into organic phases was a function of chloride ion concentration, and best results could only be achieved with NaC1 saturation of the aqueous medium. Even under these conditions, transfer was less than quantitative. It was also noted that extraction was somewhat pH-dependent, and the present authors observed a fall-off in extractive recovery at pH values above approximately 6. Further chemical manipulation of aqueous media containing tissue and whole blood residues was necessary, dictated by conditions for optimal release of trimethyl lead and its metabolites from experimental animal tissue samples. These steps are described in the next section.
Optimization of Lead Release from Tissues
As with any speciation analysis methodology involving biological samples, chemical conditions were required which would simultaneously preserve the chemical identity of the alkyl lead form present and allow maximum liberation from binding sites in tissue to the surrounding analytical medium. Optimization of these conditions involved both in vitro testing and in vivo studies, using administration of trimethyl lead to experimental animals at different dosages to yield lead species incorporated into tissue matrices at different concentrations. Use of tissues from treated animals served as a check on the degree to which in vitro "spiking" practices, although universally employed in methodology development, accurately reflect release from tissue binding sites after in vivo exposure.
In the early stage of the study, total lead in blood of treated animals was determined by the Ediger and Coleman modification (9) of the Delves Cup (10) micro-method of flame AAS. It became apparent that large losses of lead were occurring with this technique, since the level of trimethyl lead, determined as such, was much higher than total metal content. It is the blood binding of trimethyl lead, in vivo, that accounts for this anomaly. Trimethyl lead added to control rat blood in vitro did not pose any problems, indicating biological binding of trimethyl lead was associated with organolead volatilization in the preignition step. It was also determined that the problem was not seen when ethyl lead compounds are administered to animals. The authors therefore chose to carry out tameless AAS analysis.
Trimethyl lead was found to be relatively stable to demethylation in 3N HCI for at least 24 hr, as determined by extraction and HPLC analysis. Higher acidity resulted in reduced alkyl lead recovery, while more dilute acid solution was subsequently found to be only partially effective in promoting lead release from tissues with in vivo incorporation.
Direct extraction of trimethyl lead from 3N HCI, further saturated with NaCI, was seen to yield variable recovery data. Satisfactory results could be obtained if prior treatment of the isolated acid medium was carried out with dilute NaOH (3N) to a pH of approximately 4, using pyridine-2-azodimethylaniline as indicator.
Optimization of the liberation of trimethyl lead and its metabolites from tissue involved examination of the behavior of lead species from tissues of trimethyl lead-exposed rats. Soft tissue homogenates or diluted whole blood samples were treated with ultrapure hydrochloric acid to a final concentration of 3N, and release of lead in all forms (including trimethyl lead) monitored as a function of time. Aliquots of the various tissues were subjected to wet acid digestion in 5007o ultrapure nitric acid as a reference method for total lead content. This was done by adding one volume of concentrated acid to one volume of the homogenate. Virtually quantitative release of all tissue-bound lead from in vivo exposure was achieved after 18 hr of acid contact with the HC1. The relative total lead recovery from various tissues is tabulated in Table I for the HCI treatment method compared to total lead obtained by wet acid digestion. Data show that there was essentially quantitative release of all lead forms present using 3NHC1 and a partial digestion period of 18 hr, except for whole blood. Recovery values exceeding 100~ appeared to be due to a small amount of lead contained in the sample vessels.
The variance in the relative recovery data in Table I contained both interanimal biological variability and analytical variance components. The contribution of analytical variance was the major factor, explaining approximately 85070 (based on separate analyses) of within animal/within tissue samples analyzed in replicate.
The major step in the method, in terms of analytical variance, appeared to be the partitioning of the alkyl lead into the organic phase. For this reason, percent recovery and precision data for the extraction step in analysis of trimethyl lead was determined using three levels of trimethyl lead spiked into whole blood or tissue homogenate, followed by acid treatment for 18 hr as done with tissues from trimethyl lead-treated animals. These results are presented in Table II . The recovery results appear to be relatively independent of spiking level over the range studied. A typical chromatogram of the HPLC analysis of organic extracts containing trimethyl lead (0.05 t~g Pb/mL, mean of quadruplicate injections) is in Figure 1 .
Standard curves for trimethyl lead added to tissue homogenate or whole blood were linear up to the highest level actually treated, 1.6 #g Pb/mL homogenate or whole blood.
Discussion
Brinckman et al. (7, 8) have described the successful use of cation-exchange HPLC in the speciation analysis of various * *Spiking and recovery levels are given as Pb concentration.
9 " * Recovery of alkyl Pb from organic extract.
organotin compounds in aqueous media, using citrate buffer in methanol-water mixtures as eluent. These same column and mobile phase systems have been employed in the specific analysis of trimethyl lead in experimental animal tissues. Therefore, it would appear that cation-exchange HPLC has rather broad utility in the analysis of ionic organometallic species in diverse media. While mixtures of organometallic compounds have also been reported to be successfully analyzed on reversed-phase HPLC columns (6) , it has been the authors' experience that such systems appear to pose problems for analysis at the ultratrace (sub part-per-million) levels. It is often the case, as in the present study of mammalian tissues, that techniques for non-destructive liberation of organometallic analytes from biological media are as important as the particular methodology subsequently employed to quantitate the liberated material. In this case, the treatment of diverse mammalian tissue samp' :s with dilute HCI (3N) for a specified period of time (18 hr) permitted release of all forms of lead present in tissues of animals administered trimethyl lead. Furthermore, these conditions did not affect the original levels of trimethyl lead. These observations, then, subsequently allowed the use of organolead spiking standards in control animal tissues under these same conditions for routine, reliable quantitation of organo-and total lead.
Other methods of sample matrix decomposition which do not affect organometal forms have also been described in the literature. Chau etal. (1 l) reported that alkaline solubilization of such media as fish tissue, sediments, and aquatic flora using quaternary ammonium bases was satisfactory. These investigators, however, did not unequivocally determine that all alkyl lead forms plus inorganic lead were totally liberated from biochemical binding sites, and subsequently underwent chelation extraction. Also, certain mammalian tissues, particularly whole brain or brain regions, yielded inconsistent results for both total and organolead when alkaline solubilization was attempted. Hence, the choice of method of analyte release resided in the nature of the analytical matrix.
The quantitative partitioning of trimethyl lead into an organic phase from HCl-treated tissue samples could not be achieved without the use of additional steps such as successive extractions, preconcentration, etc. This paralleled the experience of De Jonghe et al. (5) , who reported a 75070 single-extraction efficiency for aqueous samples.
Very little systemic trimethyl lead appeared to undergo de- methylation to dimethyl lead. Furthermore, available information would indicate that the dimethyl lead metabolite, if present in tissues in some amount, would not survive the chemical conditions of sample treatment (12) , nor would dimethyl lead likely be extracted under the conditions reported here (11) . With some modifications, the approach described in this report could also be applied to the study of the metabolic fate of tetramethyl lead, which is extensively transformed in vivo to the trimethyl metabolite. A prior extraction of tissue homogenate with hexane or heptane at a low organic/aqueous ratio would remove tetramethyl lead for independent analysis without removing any trialkyl species. For example, Chakraborti etal. (13) noted that hexane extraction of aqueous samples at a 1:100 v/v ratio totally removed tetraalkyl lead species.
